Limerick East): I am informed that the tribunal of inquiry on hepatitis C has had no effect on the work of the compensation tribunal which has continued to hear claims and to arrange the listing and hearing of claims for future dates.
The scheme to compensate certain persons who have contracted hepatitis C from the use of human immunoglobulin-anti-D, whole blood or other blood products was formally established in December 1995. The compensation tribunal commenced hearings in January 1996 and regular hearings commenced in March 1996.
When the compensation scheme was established, it provided for a period of one month from the date of notification of an award by the compensation tribunal for a claimant to consider whether to accept or reject an award. In November 1996, I amended Clause 5(i) of the compensation scheme to allow that the period for consideration of an award by a claimant be extended until one month after the report of the tribunal of inquiry is published, or one month after the date or receiving notice of the award, whichever shall occur later.
Of the 99 awards made since 24 October 1996, 26 are still under consideration by the claimants. The compensation tribunal is not in a position to state how many of these claimants are awaiting the outcome of the tribunal of inquiry before making a decision in relation to accepting or rejecting their award.
The number of cases heard by the compensation tribunal each month since it commenced in January 1996 is as follows: